JNJ

229.64

+0.81%↑

UNH

369.73

+0.08%↑

TMO

476.34

+1.91%↑

ISRG

454.78

+0.68%↑

ABT

90.61

-1.86%↓

JNJ

229.64

+0.81%↑

UNH

369.73

+0.08%↑

TMO

476.34

+1.91%↑

ISRG

454.78

+0.68%↑

ABT

90.61

-1.86%↓

JNJ

229.64

+0.81%↑

UNH

369.73

+0.08%↑

TMO

476.34

+1.91%↑

ISRG

454.78

+0.68%↑

ABT

90.61

-1.86%↓

JNJ

229.64

+0.81%↑

UNH

369.73

+0.08%↑

TMO

476.34

+1.91%↑

ISRG

454.78

+0.68%↑

ABT

90.61

-1.86%↓

JNJ

229.64

+0.81%↑

UNH

369.73

+0.08%↑

TMO

476.34

+1.91%↑

ISRG

454.78

+0.68%↑

ABT

90.61

-1.86%↓

Search

Cencora Inc

Deschisă

SectorSănătate

305.61 -2.05

Rezumat

Modificarea prețului

24h

Curent

Minim

298.7

Maxim

312.67

Indicatori cheie

By Trading Economics

Venit

906M

566M

Vânzări

2.2B

86B

P/E

Medie Sector

37.19

67.147

EPS

4.08

Randament dividend

0.73

Marjă de profit

0.659

Angajați

47,000

EBITDA

858M

1B

Recomandări

By TipRanks

Recomandări

Puternic Cumpărare

Prognoză pe 12 luni

+29.04% upside

Dividende

By Dow Jones

Randament dividend

Medie Sector

0.73%

2.36%

Următoarele câștiguri

6 mai 2026

Data viitoare de dividende

1 iun. 2026

Următoarea dată ex-dividende

15 mai 2026

Statistici piață

By TradingEconomics

Capitalizare de piață

-10B

60B

Deschiderea anterioară

307.66

Închiderea anterioară

305.61

Sentimentul știrilor

By Acuity

7%

93%

6 / 348 Clasament în Healthcare

Cencora Inc Grafic

Performanțele din trecut nu reprezintă un indicator fiabil al rezultatelor viitoare.

Știri relevante

29 apr. 2026, 23:53 UTC

Câștiguri

Naver Posts Weaker First-Quarter Earnings

29 apr. 2026, 23:41 UTC

Acțiuni populare

Stocks to Watch: Meta Platforms, Alphabet, Qualcomm, Amazon.com

29 apr. 2026, 23:55 UTC

Câștiguri

Samsung Electronics 1Q Net Profit Beat FactSet-Compiled Consensus

29 apr. 2026, 23:54 UTC

Câștiguri

Samsung Electronics 1Q Net KRW47.225T Vs. Net KRW8.223T >005930.SE

29 apr. 2026, 23:52 UTC

Câștiguri

Samsung Electronics 1Q Oper Pft KRW57.233T Vs. Pft KRW6.685T >005930.SE

29 apr. 2026, 23:51 UTC

Câștiguri

Samsung Electronics 1Q Rev KRW133.873T Vs. KRW79.141T >005930.SE

29 apr. 2026, 23:51 UTC

Market Talk

Nikkei May Fall Amid Uncertainty Over Mideast Conflict -- Market Talk

29 apr. 2026, 23:34 UTC

Market Talk

Gold Edges Higher on Likely Technical Recovery -- Market Talk

29 apr. 2026, 23:24 UTC

Câștiguri

CSC Financial 1Q Results Supported By Higher Income From Fees, Commission>6066.HK

29 apr. 2026, 23:24 UTC

Câștiguri

CSC Financial Gains From Changes in Fair Value on Financial Assets Also Aided Results>6066.HK

29 apr. 2026, 23:24 UTC

Câștiguri

CSC Financial 1Q Net CNY3.67B Vs. Net CNY1.84B >6066.HK

29 apr. 2026, 23:24 UTC

Câștiguri

CSC Financial 1Q Rev CNY7.70B Vs. CNY4.74B >6066.HK

29 apr. 2026, 23:22 UTC

Câștiguri

China Longyuan 1Q Net CNY1.70B, Down 14%

29 apr. 2026, 23:22 UTC

Câștiguri

China Longyuan: Power Generation Down 2.9% as of End-March

29 apr. 2026, 23:20 UTC

Câștiguri

China Longyuan: 1Q Rev From Wind Power Fell, Rev From Solar Power Rose

29 apr. 2026, 23:20 UTC

Câștiguri

China Longyuan 1Q Rev CNY7.87B, Down 3.6%

29 apr. 2026, 23:19 UTC

Câștiguri

China Vanke 1Q Loss CNY5.95B Vs. Loss CNY6.25B >000002.SZ

29 apr. 2026, 23:19 UTC

Câștiguri

China Vanke: Weak China Real Estate Market Continue to Weigh on Results>000002.SZ

29 apr. 2026, 23:19 UTC

Câștiguri

China Vanke 1Q Rev CNY28.93B Vs. CNY37.99B >000002.SZ

29 apr. 2026, 23:19 UTC

Câștiguri

China Vanke 1Q Loss Narrows>000002.SZ

29 apr. 2026, 23:18 UTC

Câștiguri

Naver1Q Net Profit Missed FactSet-Compiled Consensus

29 apr. 2026, 23:17 UTC

Câștiguri

Naver 1Q Net KRW291.00B Vs. Net KRW423.70B >035420.SE

29 apr. 2026, 23:15 UTC

Câștiguri

Naver 1Q Oper Pft KRW541.80B Vs. Pft KRW505.30B >035420.SE

29 apr. 2026, 23:15 UTC

Câștiguri

Naver 1Q Rev KRW3.241T Vs. KRW2.787T >035420.SE

29 apr. 2026, 23:13 UTC

Câștiguri

CICC: Gains From Investments in Financial Instruments Also Aided Results >3908.HK

29 apr. 2026, 23:12 UTC

Câștiguri

CICC Results Supported by Increase in Fee, Commission Income >3908.HK

29 apr. 2026, 23:11 UTC

Câștiguri

CICC 1Q Rev CNY8.83B Vs. CNY5.72B >3908.HK

29 apr. 2026, 23:11 UTC

Câștiguri

CICC 1Q Net CNY3.58B Vs. Net CNY2.04B >3908.HK

29 apr. 2026, 23:04 UTC

Câștiguri

Microsoft Reports Strong Cloud Growth, but Questions About AI Returns Persist -- WSJ

29 apr. 2026, 23:04 UTC

Câștiguri

Meta Reports Big Revenue Jump and Projected Spending Increase -- 3rd Update

Comparație

Modificare preț

Cencora Inc Așteptări

Obiectiv de preț

By TipRanks

29.04% sus

Prognoză pe 12 luni

Medie 401.86 USD  29.04%

Maxim 429 USD

Minim 360 USD

În baza a 8 analiști de pe Wall Street care oferă obiective de preț pe 12 luni pentruCencora Inc - Dist în ultimele 3 luni.

Consens privind evaluarea

By TipRanks

Puternic Cumpărare

8 ratings

6

Cumpărare

2

Păstrare

0

Vânzare

Sentiment

By Acuity

6 / 348 Clasament în Sănătate

Sentimentul știrilor

Evidențe foarte puternice de creștere

Volatilitate

Sub medie

Volumul știrilor (RCV)

Medie

Date financiare

Cheltuieli de vânzare și administrare

Cheltuieli de exploatare

Profit pre-impozitare

Vânzări

Costul vânzărilor

Profit brut din vânzări

Cheltuieli cu dobânzile pe datorie

EBITDA

Profit operațional

$

Despre Cencora Inc

Cencora, Inc. sources and distributes pharmaceutical products in the United States and internationally. The company's U.S. Healthcare Solutions segment distributes pharmaceuticals, over-the-counter healthcare products, home healthcare supplies and equipment, and related services to acute care hospitals and health systems, independent and chain retail pharmacies, mail order pharmacies, medical clinics, long-term care and alternate site pharmacies, and other customers; provides pharmacy management, staffing, and other consulting services; supply management software to retail and institutional healthcare providers; packaging solutions to institutional and retail healthcare providers; clinical trial support, product post-approval, and commercialization support services; data analytics, outcomes research, and other services for biotechnology and pharmaceutical manufacturers; pharmaceuticals, vaccines, parasiticides, diagnostics, micro feed ingredients, and other products to the companion animal and production animal markets; and sales force services to manufacturers. This segment also distributes plasma and other blood products, injectable pharmaceuticals, vaccines, and other specialty products; and offers other services to physicians who specialize in various disease states, such as oncology, as well as to other healthcare providers, including hospitals and dialysis clinics. Its International Healthcare Solutions segment provides international pharmaceutical wholesale and related service, and global commercialization services; distributes pharmaceuticals, other healthcare products, and related services to pharmacies, doctors, health centers, and hospitals; and offers specialty transportation and logistics services for the biopharmaceutical industry. The company was formerly known as AmerisourceBergen Corporation and changed its name to Cencora, Inc. in August 2023. Cencora, Inc. was founded in 1871 and is headquartered in Conshohocken, Pennsylvania.
help-icon Live chat